Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Cervomed
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
June 18, 2026
CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
June 18, 2026
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
June 12, 2026
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
June 10, 2026
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026